Reaction profile

The FDA adverse-event record for pr-ascites

15 FDA reports name pr-ascites, a lower-volume reaction in the CVM extract (VeDDRA 99662). Plate stamps and neighbourhood peers follow.

#2310 of 2,481
by report volume (all reactions)
15
reports citing this reaction
93.3%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-ASCITES has 15 reports now versus 15 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-ASCITES changes

FDA AER · VeDDRA plate

Code 99662 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 15 reports
  • DEATH-HOT 93.3%
  • BOTTOM-DECILE #2310/2481
  • PHOTO-FINISH Abomasal ulcer
  • SPECIES-DOG Dog · 12
  • DRUG-LEAD Carprofen · 5
  • DESK-WIDE 12 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abomasal ulcer (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-ASCITES

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abomasal ulcer · near15Burning sensation of… · near15Chronic hepatitis · near15Conjunctival haemorrh… · near15PR-ASCITES · this reaction15Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around PR-ASCITES

PR-ASCITES: high death-coded share in the FDA AER plate

Signature read: PR-ASCITES's 93.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 15 named reports in the openFDA extract. Death-coded share is upper-third: 14 of 15 reports (93.3% of named reports). Nearest volume peer: Abomasal ulcer (±0 reports). Lead species Dog (12). Lead co-reported drug Carprofen (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 12
Cat 2
Horse 1

Breeds Most Affected

Retriever - Labrador 2
Pit Bull 2
Domestic Shorthair 2
Shepherd Dog - German 1
Crossbred Canine/dog 1
Schnauzer - Miniature 1
Warmblood (unspecified) 1
Chihuahua 1
Doberman Pinscher 1
Retriever - Golden 1

Associated Drugs

Carprofen 5
Cefovecin 3
Dexamethasone 2
Maropitant Citrate 2
Afoxolaner 2
Fluralaner Chew Tablets 2
Maropitant 1
Milbemycin Oxime + Spinosad 1
Rabies Vaccine 1
Lyme Vaccine 1
Bordetella Vaccine 1
Moxidectin 1
Diazepam 1
Dextrose 1
Ceftiofur Crystalline Free Acid 1
Ampicillin Sodium & Sulbactam Sodium 1
Metronidazole 1
Furosemide 1
Methylprednisolone Acetate 1
Marbofloxacin 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-ASCITES (#2310 of 2,481 by report volume); death-coded 93.3%. PlainBreed reaction plate · death-coded share stamp 93.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →